Drug details
Ajovy (fremanezumab-vfrm injection)
type of CGRP Monoclonal Antibodies
Ajovy (fremanezumab-vfrm) is a calcitonin gene-related peptide antagonist indicated for the preventive treatment of migraine in adults.
The drug is often used to treat Migraine .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat
The following drugs are related to Ajovy, either as a replacement or used together:
- Aimovig (erenumab-aooe injection, for subcutaneous use)
- Axert (almotriptan malate)
- Amerge (naratriptan)
- Qulipta (atogepant tablets)
- Botox (botulinum toxin type a)
- Fioricet with Codeine (butalbital acetaminophen caffeine capsules)
- Fioricet (butalbital and acetaminophen tablets)
- Cafergot (ergotamine tartrate and caffeine)
- Trudhesa (dihydroergotamine mesylate nasal spray)
- Relpax (eletriptan hydrobromide)
- Frova (frovatriptan succinate)
- Imitrex (sumatriptan succinate)
- Imitrex Injection (sumatriptan succinate injection)
- Imitrex Nasal Spray (sumatriptan nasal spray)
- Reyvow (lasmiditan tablets)
- Maxalt (rizatriptan benzoate)
- Naratriptan (naratriptan tablets)
- Nurtec ODT (rimegepant orally disintegrating tablets, for sublingual or oral use)
- Onzetra Xsail (sumatriptan nasal powder nasal administration)
- Treximet (sumatriptan and naproxen sodium tablets)
- Zembrace-SymTouch (sumatriptan succinate subcutaneous injection, usp)
- Zavzpret (zavegepant nasal spray)
- Zomig (zolmitriptan)
- Zomig Nasal Spray (zolmitriptan nasal spray)